Kim Lewis, Ph.D.

Founder & Chairman of the Board

Therapeutic Areas

Drug	Indication	Phase
ClpP Activator Platform	Complicated drug-resistant Gram-positive bacterial infections (e.g., prosthetic joint infections, osteomyelitis, endocarditis)	Pre-clinical